Longeveron (LGVN) News Today $3.44 +0.40 (+13.16%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 19, 2024 | globenewswire.comLongeveron Announces Closing of $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesJuly 18, 2024 | globenewswire.comLongeveron Announces $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesJuly 18, 2024 | globenewswire.comLongeveron Announces $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesJuly 17, 2024 | investorplace.comLGVN Stock Alert: Longeveron Pops 18% on FDA Fast-Track DesignationJuly 10, 2024 | investorplace.comWhy Is Longeveron (LGVN) Stock Up 53% Today?July 10, 2024 | globenewswire.comLongeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Mild Alzheimer's DiseaseJuly 9, 2024 | globenewswire.comNeha Motwani Elected to Longeveron® Board of DirectorsJuly 8, 2024 | globenewswire.comGene Therapy Pioneer Roger Hajjar, MD, Elected to Longeveron® Board of DirectorsJune 19, 2024 | investorplace.com3 Penny Stocks Poised to Turn Pocket Change Into a Small Fortune by 2028June 18, 2024 | globenewswire.comLongeveron Raises $4.4 Million in Gross Proceeds from Warrant Exercise TransactionJune 17, 2024 | globenewswire.comLongeveron® to Present at the Virtual Life Sciences Investor Forum on June 20, 2024June 17, 2024 | globenewswire.comLongeveron Announces Exercise of Warrants for $4.4 Million Gross ProceedsJune 13, 2024 | investorplace.comWhy Is Longeveron (LGVN) Stock Up 46% Today?June 12, 2024 | investorplace.comWhy Is Longeveron (LGVN) Stock Up 120% Today?June 3, 2024 | globenewswire.comLongeveron® Announces Contract Development and Manufacturing Business and First ContractMay 29, 2024 | benzinga.comAcumen Pharmaceuticals Stock (NASDAQ:ABOS), Quotes and News SummaryMay 28, 2024 | globenewswire.comLongeveron® to Attend BIO International Convention 2024May 17, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), Longeveron (LGVN) and EDAP TMS (EDAP)May 14, 2024 | investorplace.comLGVN Stock Earnings: Longeveron Beats EPS, Beats Revenue for Q1 2024May 14, 2024 | globenewswire.comLongeveron Announces First Quarter 2024 Financial Results and Provides Business UpdateMay 10, 2024 | globenewswire.comLongeveron Announces Board of Directors Planned TransitionsMay 2, 2024 | globenewswire.comLongeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024May 1, 2024 | finance.yahoo.comLongeveron Inc. (LGVN)April 25, 2024 | globenewswire.comLongeveron to Present at the Planet MicroCap ShowcaseApril 20, 2024 | investing.comLongeveron secures $11.4 million from warrant exercisesApril 18, 2024 | globenewswire.comLongeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public OfferingApril 17, 2024 | globenewswire.comLongeveron Announces Exercise of Warrants for $6.2 Million Gross ProceedsApril 15, 2024 | msn.comLongeveron stock rallies 85% on Alzheimer's presentation (update)April 15, 2024 | msn.comWhat's Going On With Longeveron Stock?April 15, 2024 | markets.businessinsider.comWhy Is Longeveron (LGVN) Stock Up 48% Today?April 15, 2024 | finance.yahoo.comLongeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)April 15, 2024 | globenewswire.comLongeveron's CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer's Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer's Association International Conference (AAIC)April 15, 2024 | investorplace.comWhy Is Longeveron (LGVN) Stock Up 48% Today?April 13, 2024 | finance.yahoo.comChief Scientific Officer Joshua Hare Acquires 148,936 Shares of Longeveron Inc (LGVN)April 13, 2024 | insidertrades.comMohamed Wa'el Ahmed Hashad Acquires 10,638 Shares of Longeveron Inc. (NASDAQ:LGVN) StockApril 11, 2024 | globenewswire.comLongeveron Announces Closing of $5.2 Million Public OfferingApril 8, 2024 | globenewswire.comLongeveron Announces Pricing of $5.25 Million Public OfferingApril 8, 2024 | globenewswire.comLongeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and GoalsApril 8, 2024 | investorplace.comWhy Is Longeveron (LGVN) Stock Up 82% Today?March 27, 2024 | marketbeat.comLongeveron Inc. (NASDAQ:LGVN) Sees Large Decline in Short InterestLongeveron Inc. (NASDAQ:LGVN - Get Free Report) was the target of a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 15,400 shares, a drop of 92.0% from the February 29th total of 192,900 shares. Based on an average daily trading volume, of 29,800 shares, the days-to-cover ratio is presently 0.5 days. Currently, 0.2% of the company's stock are short sold.March 27, 2024 | marketbeat.comTrading was temporarily halted for "LGVN" at 07:03 PM with a stated reason of "News pending."March 19, 2024 | globenewswire.comLongeveron Announces 1-for-10 Reverse Stock SplitMarch 1, 2024 | finance.yahoo.comLongeveron Full Year 2023 Earnings: EPS Misses ExpectationsFebruary 29, 2024 | seekingalpha.comLongeveron Inc. (LGVN) Q4 2023 Earnings Call TranscriptFebruary 29, 2024 | investing.comLongeveron LLC earnings missed by $0.81, revenue topped estimatesFebruary 28, 2024 | finance.yahoo.comLongeveron Inc. (NASDAQ:LGVN) Q4 2023 Earnings Call TranscriptFebruary 27, 2024 | benzinga.comRecap: Longeveron Q4 EarningsFebruary 27, 2024 | globenewswire.comLongeveron Reports Year-End 2023 Results and Provides Corporate UpdateFebruary 22, 2024 | benzinga.comLongeveron Stock (NASDAQ:LGVN) Dividends: History, Yield and DatesFebruary 21, 2024 | finance.yahoo.comLongeveron to Report Year-End 2023 Results and Provide Corporate Update February 27, 2024 Get Longeveron News Delivered to You Automatically Sign up to receive the latest news and ratings for LGVN and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here LGVN Media Mentions By Week LGVN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LGVN News Sentiment▼0.290.62▲Average Medical News Sentiment LGVN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LGVN Articles This Week▼21▲LGVN Articles Average Week Get Longeveron News Delivered to You Automatically Sign up to receive the latest news and ratings for LGVN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VINC News BCLI News LSTA News PLUR News EYEN News OVID News CNTB News THTX News VTVT News SLS News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LGVN) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored4 Steps to Survive the Coming Market CrashCracks threaten us with a widespread collapse unlike anything we've seen in our lifetime. During this prese...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Longeveron Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Longeveron With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.